| Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 397 (10285), 1637, 2021 | 1694* | 2021 |
| Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial O Abani, A Abbas, F Abbas, M Abbas, S Abbasi, H Abbass, A Abbott, ... The Lancet 399 (10325), 665-676, 2022 | 76 | 2022 |
| Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial O Abani, A Abbas, F Abbas, M Abbas, S Abbasi, H Abbass, A Abbott, ... The Lancet 399 (10320), 143-151, 2022 | 45 | 2022 |
| Overlap of parafermionic zero modes at a finite distance RLRC Teixeira, A Haller, R Singh, A Mathew, EG Idrisov, LGGVD da Silva, ... Physical Review Research 4 (4), 043094, 2022 | 4 | 2022 |
| Proposal for a solid-state magnetoresistive Larmor quantum clock A Mathew, KY Camsari, B Muralidharan Physical Review B 105 (14), 144418, 2022 | 2 | 2022 |
| The tunnel-time problem and a solid-state platform for quantum metrology via weak value enhancement B Muralidharan, M Subramanian, A Mathew, K Camsari Bulletin of the American Physical Society, 2024 | | 2024 |
| Resonant weak-value enhancement for solid-state quantum metrology M Subramanian, A Mathew, B Muralidharan Physical Review Applied 20 (4), 044065, 2023 | | 2023 |
| Resonant tunneling enhanced weak value amplification for solid-state quantum metrology B Muralidharan, A Mathew, M Subramanian APS March Meeting Abstracts 2023, N70. 015, 2023 | | 2023 |
| Overlap of parafermionic zero modes at a finite distance R Levy Ruscio Castro Teixeira, A Haller, E Idrisov, R Singh, A Mathew, ... APS March Meeting Abstracts 2023, W25. 015, 2023 | | 2023 |
